Cannara Biotech Inc. reported earnings results for the first quarter ended November 30, 2021. For the first quarter, the company reported sales was CAD 0.899004 million compared to CAD 0.556932 million a year ago. Revenue was CAD 6.56 million compared to CAD 1.37 million a year ago.

Net loss was CAD 0.530499 million compared to CAD 3.5 million a year ago.